Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2020
Home
2020
March 4, 2020
Published by
Tiffany McMillan
on
March 4, 2020
Categories
Appendix 3G – Notification of issue, conversion or payment up of equity +securities
February 4, 2020
Published by
Tiffany McMillan
on
February 4, 2020
Categories
Cellmid’s evolis patent to be granted in China
January 30, 2020
Published by
Tiffany McMillan
on
January 30, 2020
Categories
Cellmid Limited notes to the Appendix 4C
January 6, 2020
Published by
Tiffany McMillan
on
January 6, 2020
Categories
Key Midkine Antibody Patents granted in the US and Europe
Prev page
1
2
3
4
5
6
7
8
9
